TickerKhojComparison · NSE · data 2026-11-03
Emcure Pharmaceuticals Limited vs Neuland Laboratories Ltd.
In plain words
Size: Emcure Pharmaceuticals Limited is about 1.4 times the market value of Neuland Laboratories Ltd..
Valuation (P/E): Neuland Laboratories Ltd. 50.5 vs Emcure Pharmaceuticals Limited 35.3.
Profit growth over 3 years: Neuland Laboratories Ltd. 30.6% a year vs Emcure Pharmaceuticals Limited 20.2% a year.
Debt to equity: Emcure Pharmaceuticals Limited 0.31 vs Neuland Laboratories Ltd. 0.16.
Differences in the numbers, not a recommendation of either stock.
Side by side
| EMCURE | NEULANDLAB | |
|---|---|---|
| Price | ₹1,883.5 | ₹19,575 |
| Market cap | ₹35,440 cr | ₹25,276 cr |
| P/E | 35.3 | 50.5 |
| P/B | — | — |
| ROE | 19.7% | 21.4% |
| ROCE | 22.6% | 23.8% |
| Debt / equity | 0.31 | 0.16 |
| Operating margin | 15.2% | 28.0% |
| Dividend yield | 0.19% | 0.17% |
| Sales growth, 3 years (yearly) | 15.4% | 19.3% |
| Profit growth, 3 years (yearly) | 20.2% | 30.6% |
| 1-year return | 41.6% | 21.1% |
| Revenue, last 12 months | ₹9,683 cr | ₹2,372 cr |
| Net profit, last 12 months | ₹1,011 cr | ₹498 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹294 cr | ₹148 cr |
| Quarter profit vs a year earlier | +42.1% | +962.4% |
| Promoter holding | 77.82% | 32.26% |
| Health check | Strong (8.5/10) | Strong (7.6/10) |
Common questions
Which has a higher P/E, Emcure Pharmaceuticals Limited or Neuland Laboratories Ltd.?
Neuland Laboratories Ltd. trades at the higher P/E (50.5 against 35.3). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Neuland Laboratories Ltd. (21.4% against 19.7%).
Which carries more debt?
Emcure Pharmaceuticals Limited has the higher debt-to-equity ratio (0.31 against 0.16).